Issue 37, 2022

Cell membrane-engineered nanoparticles for cancer therapy

Abstract

Cell membrane-coating nanotechnology involves dressing synthetic nanoparticles (NPs) with membranes derived from different types of cells to endow the NPs with the properties of a specific cell type and to further achieve precise and effective disease treatment. Of great interest is the fact that cell membranes sourced from different cell sources can give different functions to the NPs. In this review, we comprehensively lay out the major advantages of several typical cell membranes, which are derived from red blood cells (RBCs), platelets, neutrophils, immune cells, stem cells, or cancer cells, for the selective fabrication of novel nanotherapeutics and their potential to greatly advance the development of nanomedicine and improve the curative effect of cancer treatments.

Graphical abstract: Cell membrane-engineered nanoparticles for cancer therapy

Article information

Article type
Review Article
Submitted
31 3月 2022
Accepted
13 5月 2022
First published
26 5月 2022

J. Mater. Chem. B, 2022,10, 7161-7172

Cell membrane-engineered nanoparticles for cancer therapy

W. Liu and Y. Huang, J. Mater. Chem. B, 2022, 10, 7161 DOI: 10.1039/D2TB00709F

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements